NaviFUS

NaviFUS Gross Margin

The Gross Margin of NaviFUS (6872.TWO) as of Oct 16, 2026 is -26.61 %. In the previous year, Gross Margin was 35.17 % — a change of -175.68% (lower).

Gross Margin

-26.61 %

YoY

-175.68%

Last updated:

Gross Margin of NaviFUS is 2025 -26.61 % . Gross Margin of NaviFUS was 2024 35.17 % . It decreases by -175.68% lower compared to the previous year.

For NaviFUS, the gross margin of -26.6% is down versus 84.5% a few years ago.

The NaviFUS Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2022
84.47 TWD
Jan 1, 2023
52.61 TWD
Jan 1, 2024
35.17 TWD
Jan 1, 2025
-26.61 TWD
The NaviFUS Gross Margin history
YEARGross MarginYoY
-26.61 %-175.68%
35.17 %-33.15%
52.61 %-37.72%
84.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NaviFUS Stock analysis

What does NaviFUS do? NaviFUS Corp, listed on the Taiwan Stock Exchange under ticker 6872.TWO with ISIN TW0006872005, is a health care company headquartered in Taipei City, Taiwan. The company went public on June 22, 2022. NaviFUS Corp operates as a medical device company specializing in the development of two core technology platforms: focused ultrasound systems and therapeutic guidance tracking systems. The firm's focus includes the development of medical systems targeting recurrent brain tumors and Alzheimer's disease. The company's website is https://navifus.com/. NaviFUS Corp is engaged in the health care sector, specifically within the health care industry. The company's operations are centered on advancing medical technologies for neurological conditions, with an emphasis on non-invasive treatment approaches. While the company's specific products and market presence are not detailed in the provided information, its technological focus suggests a commitment to innovative solutions in neurology and neurosurgery. The firm's public listing in 2022 marks its transition into a publicly traded entity, reflecting its growth and development in the medical device sector. NaviFUS Corp's headquarters in Taipei City positions it within Taiwan's growing health care technology landscape, contributing to regional advancements in medical innovation. NaviFUS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NaviFUS stock

Gross Margin of NaviFUS is -26.61 % in 2025.

Gross Margin of NaviFUS changed from 35.17 % to -26.61 %, representing a -175.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin NaviFUS since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's NaviFUS with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — NaviFUS

All Key Metrics — NaviFUS